imiloxan has been researched along with atipamezole in 2 studies
| Studies (imiloxan) | Trials (imiloxan) | Recent Studies (post-2010) (imiloxan) | Studies (atipamezole) | Trials (atipamezole) | Recent Studies (post-2010) (atipamezole) |
|---|---|---|---|---|---|
| 45 | 0 | 21 | 530 | 64 | 143 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adan, RA; Janhunen, SK; la Fleur, SE | 1 |
| Andurkar, SV; Gulati, A; Jung, S; Leonard, MG | 1 |
2 other study(ies) available for imiloxan and atipamezole
| Article | Year |
|---|---|
Blocking alpha2A adrenoceptors, but not dopamine receptors, augments bupropion-induced hypophagia in rats.
Topics: Adrenergic alpha-Antagonists; Animals; Anti-Obesity Agents; Bupropion; Eating; Energy Intake; Energy Metabolism; Imidazoles; Isoindoles; Locomotion; Male; Meals; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-2; Receptors, Dopamine | 2013 |
Centhaquin attenuates hyperalgesia and non-evoked guarding in a rat model of postoperative pain primarily through α2B-adrenoceptors.
Topics: Analgesics; Animals; Behavior, Animal; Dose-Response Relationship, Drug; Hyperalgesia; Imidazoles; Male; Motor Activity; Naloxone; Pain, Postoperative; Piperazines; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Receptors, Opioid | 2016 |